RekrutujeFaza III
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer…
Miasta: Chęciny, Olsztyn, Poznań, Warszawa i 1 inne miastoWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza II
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Miasta: Kraków, Opole, Poznań, Przemyśl i 4 inne miastaWiek: od 18 latSponsor: Astellas Pharma Global Development Inc.
RekrutujeFaza III
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Miasta: Bydgoszcz, Częstochowa, Elbląg, Katowice i 20 innych miastWiek: od 0 latSponsor: Sanofi-Aventis Recherche & Developpement
RekrutujeFaza III
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Miasta: Bydgoszcz, Elbląg, Gdańsk, Katowice i 19 innych miastWiek: od 0 latSponsor: Sanofi-Aventis Recherche & Developpement
RekrutujeFaza III
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Miasta: Bydgoszcz, Elbląg, Jelenia Góra, Katowice i 20 innych miastWiek: od 0 latSponsor: Sanofi-Aventis Recherche & Developpement
RekrutujeFaza III
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Miasta: Bydgoszcz, Elbląg, Jelenia Góra, Katowice i 19 innych miastWiek: od 0 latSponsor: Sanofi-Aventis Recherche & Developpement
RekrutujeFaza III
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Miasta: Chorzów, Gdańsk, Gliwice, Katowice i 8 innych miastWiek: od 18 latSponsor: BioNTech SE
RekrutujeFaza III
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Miasta: Brzozów, Bydgoszcz, Gdańsk, Koszalin i 6 innych miastWiek: od 18 latSponsor: Shanghai Henlius Biotech Inc.
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza III
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Miasta: Bydgoszcz, Chorzów, Jelenia Góra, Kraków i 13 innych miastWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
Rekrutacja wkrótceFaza III
A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With…
Miasta: Koszalin, Kraków, ŁódźWiek: od 18 latSponsor: Laboratorios Farmaceuticos Rovi S.A.
Rekrutacja wkrótceFaza III
A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or…
Miasta: Białystok, Częstochowa, Gdańsk, Katowice i 11 innych miastWiek: od 18 latSponsor: Allergy Therapeutics (UK) Limited